SNT 3.03% 3.2¢ syntara limited

Ann: Pharmaxis Quarterly Investor Conference Call, page-17

  1. MrQ
    5,148 Posts.
    lightbulb Created with Sketch. 272
    re: Ann: Pharmaxis Quarterly Investor Confere... "and anticipate a 12 month recruitement period"

    That's the bit I missed. Nasty implications - and jamwolf is spot on also.

    So say trial completed and analysis completed by end 2015 and Mar-2016 FDA. Early part sample results available from mid-2015.

    So 2 more years of cash burn roughly.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
-0.001(3.03%)
Mkt cap ! $41.29M
Open High Low Value Volume
3.3¢ 3.3¢ 3.1¢ $8.754K 273.9K

Buyers (Bids)

No. Vol. Price($)
4 10862 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 210797 2
View Market Depth
Last trade - 13.08pm 18/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.